Comments
Loading...

Entero Therapeutics

ENTONASDAQ
Logo brought to you by Benzinga Data
$0.4983
-0.00160-0.32%
At close: -
$0.4998
0.001500.30%
After Hours: Jan 31, 5:44 PM EDT

Entero Therapeutics (NASDAQ:ENTO) Stock, Earnings Estimates, EPS, And Revenue

Entero Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 13
EPS
$-0.590
Quarterly Revenue
$0.00
Annual Revenue
(as of Sep 30)

Analyze the earnings history of Entero Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

Entero Therapeutics (ENTO) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %
Q32024-11-13$-0.59$-0.32-84.4 %
Q22024-10-21$-3.86$-0.32-1106.3 %

Entero Therapeutics (ENTO) Revenue

Quarterly Revenue Surprise Amount

Fiscal QuarterDate ReportedActual RevenueEstimated RevenueSurprise %

FAQ

Q

When is Entero Therapeutics (NASDAQ:ENTO) reporting earnings?

A

Entero Therapeutics (ENTO) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Entero Therapeutics (NASDAQ:ENTO)?

A

Entero Therapeutics (ENTO) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2024 for Q3 and the Actual EPS was $-0.59, which missed the estimate of $-0.32.

Q

What were Entero Therapeutics’s (NASDAQ:ENTO) revenues?

A

Entero Therapeutics (ENTO) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2024 for Q3 and the Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.